Overview
Cyclophosphamide is an antineoplastic drug used to treat cancer. It works by interfering with the growth of cancer cells, either stopping or slowing their growth. Cyclophosphamide can be used as part of combination chemo-therapy regimens for a wide variety of cancer types, including breast, lung, bladder, ovary and leukemia. Its primary side effects include nausea, vomiting, fatigue, alopecia (hair loss), and increased risk of infection. Its use is an important part of cancer treatment, as it has been found to be effective in reducing morbidity and mortality.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 8 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Zahirrah Begam Mohamed Rasheed et al. · 2023 · Biology
-
2023 · Journal of Public Health in Africa
-
T. Mahmudiono et al. · 2023 · Journal of Public Health in Africa
-
2023 · Biology
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Luján Irastorza Jesús Estuardo et al. · 2022 · Obstetrics & Gynecology International Journal
-
2022 · Dicle Üniversitesi Veteriner Fakültesi Dergisi
-
H. M. El-Nigomy et al. · 2022 · Mansoura Journal of Biology
A sample of recent works citing this journal's research on Cyclophosphamide, linking to each citing work.